Abbott Laboratories (ABT) Stock Discussion | Share discussion

Abbott Laboratories

Industry: Health Care Equipment & Services

Ticker	Exchange	ISIN
$ABT	NYSE	US0028241000
$ABT	LSE Int. Main Market	US0028241000

Recent news

Carnival Net Income dropped on 442% and Revenue dropped on 73.1%

Unisys Corp reports 4,465% Net Income growth in 2020 while 31.3% Revenue decline

Northamber Net Income surged on 1,523%

International Bus Mach Corp reports 40.7% Net Income decline in 2020 and 3.2 pp EBITDA Margin decline from 20.7% to 17.5%

Blue Prism Group plc revenue surged on 40% and EBITDA Margin surged on 28.9 pp from -78.3% to -49.4%

Tui Ag EBITDA dropped on 220% and Revenue dropped on 58.0%

Zytronic Net Income dropped on 111% and EBITDA Margin dropped on 15.0 pp from 20.6% to 5.6%

Image Scan Hldgs revenue surged on 47.3% and EBITDA Margin surged on 21.0 pp from -16.0% to 5.0%

Oxford Metrics Net Income dropped on 61.6% and Revenue dropped on 14.3%

I-Nexus Global Plc revenue dropped on 14.3%

Twit about ABT stock

Share your investment idea or question on Abbott Laboratories stock:

Latest twits on Abbott Laboratories (ABT)

No twits yet. Be the first to post!

Have a question about ABT? Ask and other investors will be eager to help you.

Have an idea about ABT? Share it with other investors.

Abbott Laboratories news

22 Jan 2020 Abbott Laboratories Net Income jumped on 55.7% and Revenue increased on 4.3%

23 Jan 2019 Abbott Laboratories Net Income jumped on 396% and EBITDA Margin increased on 2.1 pp from 20.7% to 22.8%

25 Jan 2017 Abbott Laboratories reports 68.3% Net Income decline while 1.3 pp EBITDA Margin growth from 21.3% to 22.6%

28 Jan 2016 Abbott Laboratories Net Income jumped on 93.7% in 2015 and Revenue increased slightly on 0.78%

Abbott Laboratories stock price chart

Abbott Laboratories financials

mln. $	FY2010	FY2011	FY2012

Revenue	35,167	21,407	19,050
EBITDA	8,712	8,796	4,676
Net income	4,626	4,728	5,963
CAPEX	1,015	1,492	1,795
Debt	18,918	15,415	20,476
Cash	3,648	6,813	10,802